Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

77
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
77
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

101
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
101
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

78
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

50
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
50
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

56
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
56
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

65
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
65

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry.

JAMA·2026
Same author

The ODYSSEY-HCM and MAPLE-HCM studies: the role of cardiac myosin inhibitors in hypertrophic cardiomyopathy (obstructive and non-obstructive).

European heart journal supplements : journal of the European Society of Cardiology·2026
Same author

External validation of the DSP-risk score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy-associated genetic variants.

Heart rhythm·2026
Same author

Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impact.

European heart journal·2026
Same author

Immunogenicity in Fabry Disease: Current Issues, Coping Strategies, and Future Directions.

Biomedicines·2026
Same author

Inflammatory cardiomyopathy: Position paper of the Italian Society of Cardiology Working Group on cardiomyopathies and pericardial diseases in collaboration with the Italian Society of Cardiology Working Group on cardiac magnetic resonance.

International journal of cardiology·2026
Same journal

Establishment of a CT-based prediction model for endotracheal tube size in infants aged <1 year.

Frontiers in pediatrics·2026
Same journal

Case Report: Subcutaneous sensor-augmented insulin pump therapy in a 510-g preterm infant with hyperglycemia.

Frontiers in pediatrics·2026
Same journal

Association between glucolipid metabolic indicators and the risk of suspected precocious puberty in children living with obesity: a retrospective cohort study.

Frontiers in pediatrics·2026
Same journal

Clinical and imaging features of tufted angioma in children.

Frontiers in pediatrics·2026
Same journal

Transcriptome-Inferred metabolic subtypes define prognostic and immune ecosystems in osteosarcoma at single-cell resolution.

Frontiers in pediatrics·2026
Same journal

Efficacy and anthropometric predictors of negative-pressure therapy for recurrent concealed penis in pediatric patients.

Frontiers in pediatrics·2026
See all related articles

Related Experiment Video

Updated: Oct 4, 2025

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

940

Pediatric Restrictive Cardiomyopathies.

Raffaello Ditaranto1, Angelo Giuseppe Caponetti1, Valentina Ferrara1

  • 1Cardiology Unit, Department of Experimental, Diagnostic and Specialty Medicine, IRCCS, Sant'Orsola Hospital, University of Bologna, Bologna, Italy.

Frontiers in Pediatrics
|February 11, 2022
PubMed
Summary
This summary is machine-generated.

Pediatric restrictive cardiomyopathy (RCM) is rare but serious, often leading to pulmonary hypertension and sudden death. Heart transplantation is the primary treatment for this challenging pediatric heart condition.

Keywords:
cardiomyopathyheart transplant (HTx)pediatric cardiomyopathiesrestrictive cardiomyopathy (RCM)sarcomeric cardiomyopathy

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.8K
Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

1.4K

Related Experiment Videos

Last Updated: Oct 4, 2025

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

940
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.8K
Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

1.4K

Area of Science:

  • Pediatric cardiology
  • Cardiovascular research
  • Rare pediatric diseases

Background:

  • Restrictive cardiomyopathy (RCM) is the least common pediatric heart muscle disease, affecting 2.5-3% of children.
  • Pediatric RCM is associated with poor prognosis, including pulmonary hypertension, thromboembolic events, and sudden death.
  • Medical and surgical treatments are limited, making heart transplantation the main therapeutic option.

Purpose of the Study:

  • To review the causes, clinical presentation, diagnostic evaluation, treatment, and prognosis of pediatric restrictive cardiomyopathy.
  • To provide a comprehensive overview of this rare but severe pediatric heart condition.

Main Methods:

  • Literature review of pediatric restrictive cardiomyopathy.
  • Synthesis of information on etiology, clinical features, diagnosis, treatment, and outcomes.

Main Results:

  • RCM presents with severe diastolic dysfunction and restrictive ventricular filling, normal ejection fraction, and normal wall thickness.
  • Etiologies are diverse, including genetic/familial and acquired causes, each with unique pathophysiology.
  • High mortality rates and limited treatment options underscore the need for specialized management.

Conclusions:

  • Pediatric RCM requires a thorough understanding of its varied causes and clinical manifestations.
  • Effective management strategies and timely interventions, including heart transplantation, are crucial for improving outcomes.
  • Further research into the pathophysiology and treatment of pediatric RCM is warranted.